as 04-25-2025 4:00pm EST
Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are Enterprise Health and Personal Health. All of the company's operations are held in the United States. The regions the company operates in are the Americas, EMEA, and APAC.
Founded: | 2005 | Country: | United States |
Employees: | N/A | City: | SAN RAFAEL |
Market Cap: | 11.6M | IPO Year: | N/A |
Target Price: | $5.00 | AVG Volume (30 days): | 107.1K |
Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -0.56 | EPS Growth: | N/A |
52 Week Low/High: | $0.34 - $1.53 | Next Earning Date: | 05-06-2025 |
Revenue: | $17,925,000 | Revenue Growth: | -1.94% |
Revenue Growth (this year): | 25.17% | Revenue Growth (next year): | 37.02% |
EKSO Breaking Stock News: Dive into EKSO Ticker-Specific Updates for Smart Investing
GlobeNewswire
3 days ago
Simply Wall St.
2 months ago
Simply Wall St.
2 months ago
GuruFocus.com
2 months ago
Associated Press Finance
2 months ago
GlobeNewswire
2 months ago
GlobeNewswire
2 months ago
GlobeNewswire
3 months ago
The information presented on this page, "EKSO Ekso Bionics Holdings Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.